Article
Genetic determinants of circulating GIP and GLP-1 concentrations.
JCI insight - 2 Nov 2017
Almgren Peter, Lindqvist Andreas, Krus Ulrika, Hakaste Liisa, Ottosson-Laakso Emilia, Asplund Olof, Sonestedt Emily, Prasad Rashmi B, Laurila Esa, Orho-Melander Marju, Melander Olle, Tuomi Tiinamaija, Holst Jens Juul, Nilsson Peter M, Wierup Nils, Groop Leif, Ahlqvist Emma
Abstract excerpt
The secretion of insulin and glucagon from the pancreas and the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) from the gastrointestinal tract is essential for glucose homeostasis. Several novel treatment strategies for type 2 diabetes (T2D) mimic GLP-1 actions or inhibit incretin degradation (DPP4 inhibitors), but none is thus far aimed at increasing the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
